Evidence map›Paper›PMID 35474632›Full record

ArticleIUBMB life2022

Towards a metabolomic approach to investigate iron-sulfur cluster biogenesis.

Mauro Marengo, Alex Fissore, Simonetta Oliaro-Bosso, Salvatore Adinolfi, Annalisa Pastore

Open access · hybridAbstract read
In one paragraph

Article in IUBMB life, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mauro MarengoDepartment of Drug Science and Technology, University of Turin, Turin, Italy.ORCID 0000-0002-5389-3979
Alex FissoreDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Simonetta Oliaro-BossoDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Salvatore AdinolfiDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Annalisa PastoreDepartment of Basic and Clinical Neuroscience, The Maurice Wohl Institute, King's College London, Denmark Hill Campus, London, UK.
University of Turin · ITKing's College London · GB

Funding

Alzheimer's Research, UKDementia Research Institute RE1 3556Institut PasteurMedical Research CouncilUniversity of Turin ADIS RILO 18 01
6 · The paper itself

Abstract

Iron-sulfur clusters are prosthetic groups that are assembled on their acceptor proteins through a complex machine centered on a desulfurase enzyme and a transient scaffold protein. Studies to establish the mechanism of cluster formation have so far used either in vitro or in vivo methods, which have often resulted in contrasting or non-comparable results. We suggest, here, an alternative approach to study the enzymatic reaction, that is based on the combination of genetically engineered bacterial strains depleted of specific components, and the detection of the enzymatic kinetics in cellular extracts through metabolomics. Our data prove that this ex vivo approach closely reproduces the in vitro results while retaining the full complexity of the system. We demonstrate that co-presence of bacterial frataxin and iron is necessary to observe an inhibitory effect of the enzymatic activity of bacterial frataxin. Our approach provides a new powerful tool for the study of iron-sulfur cluster biogenesis.

Indexed as

IronIron-Sulfur ProteinsCarbon-Sulfur LyasesMetabolomicsProtein BindingSulfurCarbon-Sulfur LyasesIronIron-Sulfur ProteinsSulfurCyaYdesulfuraseenzymatic activityfrataxinFriedreich's ataxiairon-sulfur cluster biogenesis

Identifiers

PMID35474632
PMCPMC9325406
OpenAlexW4225015507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.